Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate
Z. Petrovich et al., Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate, AM J CL ONC, 22(4), 1999, pp. 323-331
Citations number
29
Categorie Soggetti
Oncology
Journal title
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
Patients with localized adenocarcinoma of the prostate gland (CaP) are freq
uently (similar to 50%) found at radical prostatectomy to have extracapsula
r disease or positive surgical margins. The management of these patients is
a subject of controversy because some question the impact of this manifest
ation of CaP on patient survival or disease-free survival. Between 1976 and
1991, 241 patients with pathologic stage C (T3N0) were treated in this med
ical center. Of these 241 patients, 201 (83%) received a planned postoperat
ive pelvic irradiation consisting of 48 Gy given to the prostatic fossa, wh
ereas 40 (17%) patients were treated with radical prostatectomy alone. The
two study urologists selected these patients not to receive postoperative i
rradiation based on intraoperative findings and important prognostic factor
s. Comparison of treatment outcomes in these two treatment groups is a subj
ect of this report. The 201 patients treated with surgery-radiotherapy (S+R
T) combination had a higher pathologic stage, greater incidence of seminal
vesicle involvement, p = 0.002, and higher mean and median preoperative pro
state-specific antigen level, p < 0.0001, than the 40 surgery (S) alone pat
ients. There was no significant difference in the incidence of higher Gleas
on's score by the treatment group, p = 0.14. In univariate analysis, there
was no significant difference in survival, disease-free survival, and time
to failure between the two treatment groups. Tn multivariate analysis after
controlling for pathologic stage and Gleason's score, the 201 adjuvant rad
iotherapy patients were predicted to have recurrence at 68% (95% confidence
interval 39%-118%) the rate of the 40 surgery-alone patients. Local recurr
ence with or without metastatic disease was found in 10% of surgery-alone p
atients as compared to 5% in those also receiving postoperative irradiation
. Treatment tolerance was very good with minor radio-therapy complications
only. There was no significant difference in the incidence of incontinence
between the two treatment arms. In summary: (a) The use of moderate-dose po
stoperative radiotherapy was of low toxicity and it did not increase the in
cidence of incontinence. (b) Local recurrence was 5% in St-RT and 10% in S-
alone patients. (c) In multivariate analysis, S+RT patients had 68% rate of
recurrence of S-alone patients. (d) Adjuvant RT probably reduces the risk
of recurrence in patients with poor prognostic factors. (e) These data need
to be interpreted with caution because of the nonrandomized nature of the
study.